CY1114264T1 - STABLE AND SOLVENT ANTIBODIES THAT INHIBIT TNF (ALFA) - Google Patents

STABLE AND SOLVENT ANTIBODIES THAT INHIBIT TNF (ALFA)

Info

Publication number
CY1114264T1
CY1114264T1 CY20131100659T CY131100659T CY1114264T1 CY 1114264 T1 CY1114264 T1 CY 1114264T1 CY 20131100659 T CY20131100659 T CY 20131100659T CY 131100659 T CY131100659 T CY 131100659T CY 1114264 T1 CY1114264 T1 CY 1114264T1
Authority
CY
Cyprus
Prior art keywords
antibodies
tnfα
stable
alfa
solvent
Prior art date
Application number
CY20131100659T
Other languages
Greek (el)
Inventor
Stefan Ewert
David Urech
Peter Lichtlen
Alcide Barberis
Der Maur Adrian Auf
Original Assignee
Esbatech - A Novartis Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11002906.3A external-priority patent/EP2390267B1/en
Application filed by Esbatech - A Novartis Company Llc filed Critical Esbatech - A Novartis Company Llc
Publication of CY1114264T1 publication Critical patent/CY1114264T1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε ιδιαίτερα σταθερά και διαλυτά scFv αντισώματα και Fab τμήματα ειδικά για τον TNFα, τα οποία περιέχουν ειδικές αλληλουχίες ελαφριάς και βαριάς αλύσου, οι οποίες έχουν βελτιστοποιηθεί αναφορικά με τη σταθερότητα, τη διαλυτότητα, την in vitro και in vivo πρόσδεση του TNFα και τη χαμηλή ανοσογονικότητα. Τα αντισώματα που αναφέρονται έχουν σχεδιαστεί για τη διάγνωση ή/και αντιμετώπιση των διαταραχών που σχετίζονται με τον TNFα. Περιγράφονται επίσης νουκλεϊκά οξέα, οι φορείς και τα κύτταρα ξενιστές για την έκφραση των ανασυνδυασμένων αντισωμάτων της εφεύρεσης, οι μέθοδοι απομόνωσής τους και η χρήση των αναφερθέντων αντισωμάτων στην ιατρική.The present invention relates to highly stable and soluble scFv antibodies and Fab fragments specific for TNFα, containing specific light and heavy chain sequences that have been optimized for stability, solubility, in vitro and in vivo binding of TNFα. and low immunogenicity. The antibodies mentioned are designed to diagnose and / or treat disorders related to TNFα. Also described are nucleic acids, vectors and host cells for the expression of the recombinant antibodies of the invention, their methods of isolation and the use of said antibodies in medicine.

CY20131100659T 2005-06-07 2013-08-01 STABLE AND SOLVENT ANTIBODIES THAT INHIBIT TNF (ALFA) CY1114264T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68797105A 2005-06-07 2005-06-07
US78535306A 2006-03-23 2006-03-23
EP11002906.3A EP2390267B1 (en) 2005-06-07 2006-06-06 Stable and soluble antibodies inhibiting TNF(alpha)

Publications (1)

Publication Number Publication Date
CY1114264T1 true CY1114264T1 (en) 2016-10-05

Family

ID=58448764

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100659T CY1114264T1 (en) 2005-06-07 2013-08-01 STABLE AND SOLVENT ANTIBODIES THAT INHIBIT TNF (ALFA)

Country Status (1)

Country Link
CY (1) CY1114264T1 (en)

Similar Documents

Publication Publication Date Title
CY1123978T1 (en) FIXED AND SOLUBLE ANTIBODIES THAT INHIBIT TON TNF
CY1119647T1 (en) ALUMINUM ACCESSORIES AND ACCESSORIES FOR ACCESSORIES
CY1119941T1 (en) STABLE AND SOLUBLE PARTS
MX2007015280A (en) Stable and soluble antibodies inhibiting tnf??.
CY1123733T1 (en) GENE PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND THEIR USE
CO2020001113A2 (en) Interleukin 21 Muteins and Treatment Methods
CY1121132T1 (en) FULLY-HUMAN MONOCLONE ANTIBODIES ANTI-vap-1
AU2018298422A1 (en) Novel nucleic acid molecules
CY1114855T1 (en) ANTIBODIES AND PARTS COMING FROM THESE BINDING TO PROTEINS TOY STEAP-1
CY1118880T1 (en) HUMAN ANTI-IL-23 ANTIBODIES, COMPOSITIONS, METHODS AND USES
CY1118443T1 (en) ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USES
CY1119290T1 (en) CLAUDIN-18 MONOCLONE ANTIBODIES FOR CANCER TREATMENT
CY1119219T1 (en) ANTI-CEACAM5 ANTIBODIES AND THEIR USES
CY1117922T1 (en) HER2 / NEU-SPECIAL ANTIBODIES AND METHODS OF USE
CY1116288T1 (en) TNFSF MORIA CHAIN
EA201000207A1 (en) NEW IMMUNOGENIC EPITOPES FOR IMMUNOTHERAPY
CY1113062T1 (en) TUMORS RELATED TO TUMORS CONNECTED WITH PARTICULARS OF HUMAN LEVEL CELLS (HLA) CLASS I OR II AND RELATED ANTIQUES
CY1114584T1 (en) RECOVERABLE VACCINES AND USE OF THESE
NO20082559L (en) Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
NO20083053L (en) Human monoclonal antibodies to O8E
AR080663A1 (en) SPECIFIC UNION PROTEINS AND ITS USES
ATE504602T1 (en) BINDING PROTEINS SPECIFIC TO HUMAN MATRIPTASE
PE20050962A1 (en) FULLY HUMAN ANTIBODIES VS HUMAN 4-1BB
MX2021010281A (en) Antigen binding proteins that bind bcma.
CY1117283T1 (en) STABLE SINGLE MONOMER AND MULTILATERAL BETA Amyloid